Applied Clinical Trials-10-01-2008

The latest eClinical software in the clinical trials industry.

How the Internet is blurring the lines between patient and physician and redefining old roles.

Industry news focusing on the people and organizations who work in the clinical trials profession.

Insight into obtaining insurance for a clinical trial and if or when it should be left to the professionals.

The EU provides extensive funds to the clinical trials industry in an effort to better health care delivery.

An in depth look at industry's reaction to FDAAA, its requirements, submitting the results, and meeting the deadline.

From pre- to postmarketing, safety monitoring must be a priority that's handled with knowledgeable care.

A purely empirical approach to drug development may allow for evaluation of the overt factors that impact the balance of benefit and risk, but it will never uncover all potential scenarios for which companies are now being held accountable.

By defining hurdles to registration, emerging companies benefit from early regulatory guidance.

After almost a decade of dim progress in drug development, R&D is finally making a come back, according to current data published in Parexel International's, "The U.S. Drug Approval Trends and Yearbook 2008/2009."

The Netherlands has become the latest European country to establish a network that is designed to promote pediatric drug development.